Skip to main content
OpenTrials
Completed

NCT Number: NCT03727984

Re-hospitalized Patients With Acute Coronary Syndrome

The predictors of re-hospitalization of patients with history of acute coronary syndrome

Completed

Looking for future studies?

Notify Me

Key information

About this study

The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months

Exclusion criteria

Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients

Treatment and study plan

Primary outcomes

  1. Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome

    Time frame: Up to 1 year

    The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code

  2. Cardiovascular Hospitalization

    Time frame: Up to 1 year

    Predictive factors for patients re-admitted with acute coronary

Sponsors and collaborators

Lead sponsor

Cardiovascular Academy Society, Turkey

Other

Registry information

Official study title

Demographic, Clinical Characteristics and Medications of Re-hospitalized Patients for Acute Coronary Syndrome

Acronym: BoomerangACS

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Nov 1, 2018
Registry last updated
Jan 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.